Is ProMIS Neurosciences Inc. (PMN) overvalued? · P/E 4.8, $14.1M cap
ProMIS Neurosciences Inc. (PMN) is a biotechnology company listed on US.
This page asks whether ProMIS Neurosciences Inc. (PMN) looks expensive on cached numbers — not a short thesis.
No cached income statement for PMN, so there is no earnings base to call rich or cheap.
PMN currently screens at market cap $14.1M and trailing P/E 4.8. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next PMN 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the PMN stock page for the full model, not this heading.
Not investment advice.